Publicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (81)

2024

  1. Accuracy of Two Continuous Glucose Monitoring Devices During Aerobic and High-Intensity Interval Training in Individuals with Type 1 Diabetes

    Diabetes Technology and Therapeutics, Vol. 26, Núm. 6, pp. 411-419

  2. Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis

    Diabetes Technology and Therapeutics, Vol. 26, Núm. 8, pp. 575-586

  3. Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based study

    Diabetes Research and Clinical Practice, Vol. 207

  4. Current barriers to initiating insulin therapy in individuals with type 2 diabetes

    Frontiers in Endocrinology, Vol. 15

2023

  1. Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes

    Journal of Diabetes Science and Technology, Vol. 17, Núm. 5, pp. 1326-1336

  2. Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes

    Diabetes Therapy, Vol. 14, Núm. 4, pp. 723-736

  3. Spanish Consensus on the Use of Intermittently Scanned Continuous Glucose Monitoring in the Management of Patients With Insulin Therapy: The MONITOR Project

    Journal of Diabetes Science and Technology, Vol. 17, Núm. 5, pp. 1256-1264

  4. Which people with diabetes are treated with a disposable, half-unit insulin pen? A real-world, retrospective, database study in Spain

    Endocrinology, Diabetes and Metabolism, Vol. 6, Núm. 6

2022

  1. Diabetes and the WHO Model List of Essential Medicines

    The Lancet Diabetes and Endocrinology

  2. Effect of personality on blood glucose control in patients with type 1 diabetes

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 9, pp. 677-685

  3. Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain

    European Journal of Clinical Investigation, Vol. 52, Núm. 6

  4. The Controversial Role of Vitamin D in Thyroid Cancer Prevention

    Nutrients, Vol. 14, Núm. 13

2021

  1. Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Spanish results of a global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 8, pp. 557-566

  2. Dapagliflozin as an adjunct therapy to insulin in patients with type 1 diabetes mellitus: Efficacy and safety of this combination

    touchREVIEWS in Endocrinology, Vol. 17, Núm. 1, pp. 12-20

  3. Efficacy and safety of adding sotagliflozin, a dual sodium-glucose co-transporter (SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m2

    Diabetes, Obesity and Metabolism, Vol. 23, Núm. 3, pp. 854-860

  4. Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study

    Diabetes, Obesity and Metabolism, Vol. 23, Núm. 8, pp. 1892-1901

  5. Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents

    Journal of Diabetes and its Complications, Vol. 35, Núm. 3

  6. Time-in-range for monitoring glucose control: Is it time for a change?

    Diabetes Research and Clinical Practice, Vol. 177

2020

  1. Biosimilars and Novel Insulins

    American Journal of Therapeutics, Vol. 27, Núm. 1, pp. E52-E61

  2. Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation

    Journal of Diabetes Science and Technology